PET probes beyond 18F-FDG

被引:3
作者
Lei Jiang [1 ,2 ]
Yingfeng Tu [2 ]
Hongcheng Shi [1 ]
Zhen Cheng [2 ]
机构
[1] Department of Nuclear Medicine,Zhongshan Hospital,Fudan University
[2] Molecular Imaging Program at Stanford(MIPS),Department of Radiology,Stanford Cancer Institute,Bio-X Program,Canary Center at Stanford for Cancer Early Detection,Stanford University
关键词
PET; molecular probes; personalized medicine;
D O I
暂无
中图分类号
R816 [各部位及各科疾病的X线诊断与疗法];
学科分类号
1001 ; 100105 ; 100207 ; 100602 ;
摘要
During the past several decades,positron emission tomography(PET) has been one of the rapidly growing areas of medical imaging;particularly,its applications in routine oncological practice have been widely recognized.At present,F-fluorodeoxyglucose(F-FDG) is the most broadly used PET probe.However,F-FDG also suffers many limitations.Thus,scientists and clinicians are greatly interested in exploring and developing new PET imaging probes with high affinity and specificity.In this review,we briefly summarize the representative PET probes beyondF-FDG that are available for patients imaging in three major clinical areas(oncology,neurology and cardiology),and we also discuss the feasibility and trends in developing new PET probes for personalized medicine.
引用
收藏
页码:435 / 446
页数:12
相关论文
共 50 条
  • [41] 18F-FDG PET/CT role in Burkitt lymphoma
    Domenico Albano
    Francesco Bertagna
    Raffaele Giubbini
    Clinical and Translational Imaging, 2020, 8 : 39 - 45
  • [42] 18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis
    Skali, Hicham
    Schulman, Allison R.
    Dorbala, Sharmila
    CURRENT CARDIOLOGY REPORTS, 2013, 15 (04)
  • [43] 18F-FDG PET in detecting metastatic infectious disease
    Bleeker-Rovers, CP
    Vos, FJ
    Wanten, GJA
    van der Meer, JWM
    Corstens, FHM
    Kullberg, BJ
    Oyen, WJG
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (12) : 2014 - 2019
  • [44] Assessing PET Parameters in Oncologic 18F-FDG Studies
    Sarikaya, Ismet
    Sarikaya, Ali
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2020, 48 (03) : 278 - 282
  • [45] 18F-FDG PET imaging of muscle activity in runners
    Tashiro, M
    Fujimoto, T
    Itoh, M
    Kubota, K
    Fujiwara, T
    Miyake, M
    Watanuki, S
    Horikawa, E
    Sasaki, H
    Ido, T
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (01) : 70 - 76
  • [46] 18F-FDG Fetal Dosimetry Calculated with PET/MRI
    Zanotti-Fregonara, Paolo
    Ishiguro, Tatsuya
    Yoshihara, Kosuke
    Ishii, Shiro
    Enomoto, Takayuki
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (10) : 1592 - 1597
  • [47] 18F-FDG PET/CT in Oral Cuniculatum Carcinoma
    Dejust, Sebastien
    El Farsaoui, Khadija
    Bellefqih, Sara
    Lalire, Paul
    Morland, David
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 741 - 742
  • [48] Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
    Mistry, Vijay
    Scott, Justin R. R.
    Wang, Tzu-Yang
    Mollee, Peter
    Miles, Kenneth A. A.
    Law, W. Phillip
    Hapgood, Greg
    CANCER IMAGING, 2023, 23 (01)
  • [49] 18F-FDG PET versus 18F-FDG PET/CT for adrenal gland lesion characterization:: a comparison of diagnostic efficacy in lung cancer patients
    Sung, Yon Mi
    Lee, Kyung Soo
    Kim, Byung-Tae
    Choi, Joon Young
    Chung, Myung Jin
    Shim, Young Mog
    Yi, Chin A.
    Kim, Tae Sung
    KOREAN JOURNAL OF RADIOLOGY, 2008, 9 (01) : 19 - 28
  • [50] 18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
    Ben-Haim, Simona
    Ell, Peter
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (01) : 88 - 99